Kim, N. H., Kim, D., Kim, K. J., Kim, N. H., Choi, K. M., Baik, S. H., & Kim, S. G. (2017). Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study. Endocrinol Metab (Seoul).
Chicago Style CitationKim, Nam Hoon, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, i Sin Gon Kim. "Effects of Vildagliptin or Pioglitazone On Glycemic Variability and Oxidative Stress in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study." Endocrinol Metab (Seoul) 2017.
Cita MLAKim, Nam Hoon, et al. "Effects of Vildagliptin or Pioglitazone On Glycemic Variability and Oxidative Stress in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study." Endocrinol Metab (Seoul) 2017.